Prior Percutaneous Coronary Intervention and Mortality in Patients Undergoing Surgical Myocardial Revascularization: Results From the E-CABG (European Multicenter Study on Coronary Artery Bypass Grafting) With a Systematic Review and Meta-Analysis

Giovanni Mariscalco, Stefano Rosato, Giuseppe F Serraino, Daniele Maselli, Magnus Dalén, Juhani K E Airaksinen, Daniel Reichart, Marco Zanobini, Francesco Onorati, Marisa De Feo, Riccardo Gherli, Giuseppe Santarpino, Antonino S Rubino, Giuseppe Gatti, Francesco Nicolini, Francesco Santini, Andrea Perrotti, Vito D Bruno, Vito G Ruggieri, Fausto Biancari

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The clinical impact of prior percutaneous coronary intervention (PCI) in patients requiring coronary artery bypass grafting (CABG) remains unsettled. We sought to determine whether prior PCI is associated with adverse outcome after CABG.

METHODS AND RESULTS: Data from the prospective E-CABG (European Multicenter Study on Coronary Artery Bypass Grafting) conducted between January 2015 and March 2016 at 16 European centres were analyzed using propensity weighted methodology to adjust for confounding. A parallel systematic review/meta-analysis (MEDLINE, Embase, SCOPUS, and Cochrane Library) through September 2017 was accomplished. Of a total of 3641 adult patients included in the E-CABG study, 685 (19%) patients had a history of PCI. At multivariable level, prior PCI was not associated with an increased hospital mortality in both unweighted and weighted patient groups (odds ratio, 0.73; 95% confidence interval, 0.29-1.38; P=0.33 and odds ratio, 0.90; 95% confidence interval, 0.39-2.08; P=0.81, respectively). Subgroup analyses confirmed that prior PCI had no impact on hospital mortality and morbidity, including reexploration for bleeding, blood transfusion, hospital resource use, and neurological, renal, and cardiac complications. The systematic review provided a total of 71 366 individuals and showed a trend toward higher in-hospital/30-day mortality (adjusted odds ratio, 1.30; 95% confidence interval, 0.99-1.70; I2=43.1%) in patients with prior PCI.

CONCLUSIONS: Our prospective multicenter study showed that prior PCI was not associated with an increased risk of mortality or other adverse outcomes in patients undergoing CABG. In light of a trend toward increased mortality observed in the meta-analysis, further studies are needed to ascertain the prognostic impact of prior PCI in the outcome after CABG.

CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02319083.

Original languageEnglish
Pages (from-to)e005650
JournalCirculation. Cardiovascular interventions
Volume11
Issue number2
DOIs
Publication statusPublished - 2018

    Fingerprint

Keywords

  • Coronary intervention
  • Mortality
  • myocardial revascularization
  • Meta-analyses
  • Coronary artery bypass graft

Cite this

Mariscalco, G., Rosato, S., Serraino, G. F., Maselli, D., Dalén, M., Airaksinen, J. K. E., Reichart, D., Zanobini, M., Onorati, F., De Feo, M., Gherli, R., Santarpino, G., Rubino, A. S., Gatti, G., Nicolini, F., Santini, F., Perrotti, A., Bruno, V. D., Ruggieri, V. G., & Biancari, F. (2018). Prior Percutaneous Coronary Intervention and Mortality in Patients Undergoing Surgical Myocardial Revascularization: Results From the E-CABG (European Multicenter Study on Coronary Artery Bypass Grafting) With a Systematic Review and Meta-Analysis. Circulation. Cardiovascular interventions, 11(2), e005650. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005650